OSSOS-SANS Reforzado con: Glucosamina Curcuma Ortiga tablets recall
FDA recall D-0558-2024 · initiated May 22, 2024
MexHealth LLC recalled OSSOS-SANS Reforzado con: Glucosamina Curcuma Ortiga tablets in May 2024 — an FDA Class II recall (D-0558-2024) because Marketed Without An Approved NDA/ANDA: FDA laboratory analysis found the product to contain undeclared diclofenac and methocarbamol,.
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
Marketed Without An Approved NDA/ANDA: FDA laboratory analysis found the product to contain undeclared diclofenac and methocarbamol,
Sold unapproved, or found to contain something undeclared
The product should not have been on sale in this form — often a supplement found to contain a hidden prescription drug.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Quantity recalled: 20 bottles
Details
- Product
- OSSOS-SANS Reforzado con: Glucosamina Curcuma Ortiga tablets, packaged in a 30-count bottle, DISTRIBUIDOR POR: Naturistas Especializados, Alce Blanco 180-A Fracc. Industrial, Edo. de Mexico C.P. 53370
- Recalling company
- MexHealth LLC
- Classification
- Class II
- Status
- Ongoing
- Type
- Voluntary: Firm initiated
- Distribution
- US Nationwide
- Initiated
- May 22, 2024
- FDA report date
- Jun 26, 2024
Frequently asked
- Was OSSOS-SANS Reforzado con: Glucosamina Curcuma Ortiga tablets recalled?
- MexHealth LLC recalled OSSOS-SANS Reforzado con: Glucosamina Curcuma Ortiga tablets in May 2024 — an FDA Class II recall (D-0558-2024) because Marketed Without An Approved NDA/ANDA: FDA laboratory analysis found the product to contain undeclared diclofenac and methocarbamol,. May cause temporary or medically reversible harm; low probability of serious harm.
- Why was OSSOS-SANS Reforzado con: Glucosamina Curcuma Ortiga tablets recalled?
- Per the FDA enforcement record, the reason for recall D-0558-2024 was: Marketed Without An Approved NDA/ANDA: FDA laboratory analysis found the product to contain undeclared diclofenac and methocarbamol,
- Is a recalled OSSOS-SANS Reforzado con: Glucosamina Curcuma Ortiga tablets dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of OSSOS-SANS Reforzado con: Glucosamina Curcuma Ortiga tablets are affected?
- Distributed: US Nationwide. The recall covers these lots — Lot Number: H29585, No Expiration date. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0558-2024.